Chimeric Therapeutics Ltd receives IND clearance from US FDA for CHM 1101 for Glioblastoma

With this foundational IND, Chimeric will also further advance plans for a phase-I basket trial in solid tumours and a phase-II registration trial in...

Related Keywords

Jennifer Chow ,Drug Administration ,Investigational New Drug ,ஜெனிபர் சோவ் ,Small Caps ,Harma Biotech ,Chimeric Therapeutics Ltd ,Asx Chm ,Roactiveinvestors ,